Devin Connor and I had the privilege of presenting Diagnostic Ventures, LLC at the AZBIO White Hat Investor Conference last week! t was a great event hosted by Joan Koerber-Walker the President and CEO of AZ BIO! We discussed how we have a patented solution to detect Sepsis from whole blood in 1 hour. This technology was developed at BYU with $5.2 million in funding from the NIH. It was well attended by Angels, Family offices and VC groups. We are having additional meetings with interested investors! www.diagnosticventures.net
Diagnostic Ventures
Biotechnology Research
A biotechnology focused company dedicated to improving medical diagnostics.
About us
Diagnostic Ventures is a company focused on creating novel diagnostic medical technologies. Annually, sepsis affects 50 million people worldwide, with over 10 million deaths. Our company has a patented process that uses blood from a patient presenting with sepsis symptoms and produces results within 2 hours which identifies the most dangerous antimicrobial resistant genes present in bacteria that cause bloodstream infections. Our Rapid Sepsis test will help save lives, by quickly identifying patients who have this type of infection and providing doctors the tools to quickly prescribe the right antibiotics for sepsis infections.
- Website
-
www.diagnosticventures.net
External link for Diagnostic Ventures
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Partnership
Updates
-
Glad to see our team is meeting with advisors and gaining exposure with key opinion leaders from hospitals the world over. Thanks to American Thoracic Society for including us in your Clinical Trial Awareness section.
I’m excited to represent Diagnostic Ventures at the American Thoracic Society 2024 conference in San Diego! We’re here to increase awareness of our upcoming clinical trials as we march forward in our mission to save lives and improve patient outcomes by commercializing our 1 Hour Sepsis Assay which was acquired from BYU Technology Transfer. Pictured below with Brian Bentley and me are: Dr. Matt Alder & Ghazi Kashmolah (L to R)
-
-
We're excited for our Founder, Brian Bentley, to share our revolutionary technology with everyone at Kinect Capital's Investors Choice event! #sepsis #sepsisalliance #diagnostics
Come see Diagnostic Ventures and Proactive Health at the upcoming 41st Annual Investors Choice, happening in about a week! Proactive Health utilizes cutting-edge tech to catch health issues promptly, decreasing hospital visits with broad insurance support including HMOs. Diagnostic Ventures introduces a quick sepsis screening that pinpoints critical pathogens in under 90 minutes, funded by an NIH grant. This innovative, awaiting FDA-approval test aims to slash sepsis mortality rates through accelerated detection and treatment. Secure your spot now to experience their live presentations! Tickets are available—click the link in the comments. #smallbusinesses #pitchevent #utahevents #investorschoice2024
-
-
Diagnostic Ventures was one of the few companies selected to present at Kinect Capital's: INVESTORS CHOICE 2024 ⛵ You're invited to join us at the 41st Annual Investors Choice, Utah's premier start-up pitch event! https://lnkd.in/gxHXjjDx This year's theme of "The Rising Tide Lifts All Boats" serves as the central theme for connecting startup founders, mentors, and investors in a shared journey toward success. This event underscores the idea that when one startup flourishes, it creates opportunities for others and generates momentum for the entire ecosystem. Join us for a revolutionary day-long event for redefining rules, breaking barriers, and establishing Utah as the heart of the greatest startup ecosystem on Earth! Click the link in the comments below to learn more! #startup #pitchevent #growyourbusiness #growingbusiness #Utahbusiness #Utahstartups
-